Skip to main content
U.S. flag

An official website of the United States government

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

Search help
15 results
  1. NLM Digital Collections - Hospital literature index (Volume 46) 
    resource.nlm.nih.gov/7807587X33
    ... PARENTERAL HYPERALIMENTATION ECONOMICS Implementing therapeutic interchange of intravenous famotidine for cimetidine and ranitidine. Oh T, et al. ... 7):1551-4 Implementing therapeutic interchange of intravenous famotidine for cimetidine and ranitidine. Oh T, et al. ...
  2. NLM Digital Collections - Treatment options for gastroesophageal reflux disease : scientific review 
    Publication: [Oakland, Calif.] : California HealthCare Foundation, c2004
    resource.nlm.nih.gov/101244756
    ... mg - 1.6 g $93 - $187 $55 - $109 $$$ $$$ & s Famotidine (Pepcid®) 20 mg – 40 mg $84 - $112 $8 - $ ... 400 mg $8 - $18 $6 - $11 $ $ q q Famotidine (Pepcid AC®) 10 mg – 20 mg $8 - $16 $ ...
  3. NLM Digital Collections - Beikoku Kokuritsu Igaku Toshokan bunruihō : igaku oyobi kanren bun'ya ni okeru tosho haikahō 
    Publication: Tōkyō : Nihon Igaku Toshokan Kyōkai, 1996
    resource.nlm.nih.gov/9704321
    ... Family Characteristics Family Therapy WM 430.5.F2 Famotidine As an anti-ulcer agent QV 69 Famous ... ttzimftlBtYjcofzsbcoiiCOUXMM iz 7 7 -t 7 x* X (Famotidine) tlikmnb LT QV 69 Xr o-H$:ffi ( ...
  4. NLM Digital Collections - Hospital literature index (Volume 50) 
    resource.nlm.nih.gov/7807587X37
    ... 7 Use of i.v. cimetidine, ranitidine, and famotidine in 40 hospitals. Segal R, et al. Am ... 32610.): Use of i.v. cimetidine, ranitidine, and famotidine in 40 hospitals. Am J Hosp Pharm 1993 ...
  5. NLM Digital Collections - Antithrombotics : indications and management : a national clinical guideline 
    Publication: Edinburgh, Scotland : Scottish Intercollegiate Guidelines Network (SIGN), August 2012
    resource.nlm.nih.gov/101609426
    ... developed over 12 weeks among patients assigned to famotidine (3.8%) than to placebo (23.5%; 1+ ... Taha AS, McCloskey C, Prasad R, Bezlyak V. Famotidine 2012. London: British Medical Association and Royal for ...
  6. NLM Digital Collections - Waiver of in vivo bioavailability and bioequivalence studies for immediate-release solid oral ... 
    Publication: Silver Spring, MD : Center for Drug Evaluation and Research, December 2017
    resource.nlm.nih.gov/101720038
    ... Enalapril Furosemide Metformin Amiloride Atenolol Ranitidine Low Permeability Famotidine (fa < 50 percent) Nadolol Sulpiride Lisinopril Acyclovir Foscarnet ...
  7. NLM Digital Collections - Part D plans generally include drugs commonly used by dual eligibles : 2018 
    Publication: [Washington, D.C.] : U.S. Department of Health and Human Services, Office of Inspector General, June 2018
    resource.nlm.nih.gov/101738033
    ... 2,400,044–3,854,879 386 100% Famotidine 751 3,076,189 2,392,508–3, ...
  8. NLM Digital Collections - National Library of Medicine classification : a scheme for the shelf arrangement of library ... 
    Publication: Bethesda, Md. : U.S. Dept. of Health and Human Services, Public Health Service, National Institutes of Health, National Library of Medicine ; Washington, D.C. : For sale by the Supt. of Docs., U.S. G.P.O., 1994
    resource.nlm.nih.gov/9440818
    ... Family Characteristics Family Therapy WM 430.5.F2 Famotidine As an anti-ulcer agent QV 69 Famous ...
  9. NLM Digital Collections - Children's health spending : 2010-2014 
    Publication: Washington, DC, : Health Care Cost Institute, May 2016
    resource.nlm.nih.gov/101712065
    ... increase in average price over drugs, for example famotidine, which study period. The highest average the study ...
  10. NLM Digital Collections - Prescribing errors that cause harm 
    Publication: [Harrisburg, Pennsylvania] : Pennsylvania Patient Safety Authority, September 2016
    resource.nlm.nih.gov/101693067
    ... succinate], IV Pepcid® Patient transferred to another Allergy [famotidine], and subcutaneous facility for shortness of breath. Patient ...
previous · 1 · 2 · next